))
JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview
Manage episode 337237106 series 3380326
Content provided by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Interview with Philip Greenland, MD, author of Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals. Summary Points:
- In comparison with other competing biomarkers and risk factors, coronary artery calcium (CAC) is currently the most potent risk marker of subclinical coronary heart disease (CHD).
- CAC was shown in several observational studies to improve the prediction of risk beyond traditional risk factors.
- In this JAMA paper, CAC outperformed various competing risk assessment markers among asymptomatic people at intermediate risk for CHD. Whether CAC should be used in routine clinical practice, however, is still a matter of personal opinion or further research.
97 episodes
Share
